Why biological data matters more in AI drug discovery

GSK has entered into a research collaboration with British biotechnology company Relation Therapeutics worth up to $110 million, expanding the companies’ existing work in AI-assisted drug discovery. Under the agreement, Relation will generate large-scale datasets measuring how human cells respond to genetic changes and drug interventions. The data will be used to train AI models […] The post Why biological data matters more in AI drug discovery appeared first on AI News.